Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VISTAS trial of volixibat for cholestatic pruritus in primary sclerosing cholangitis
MOH_2021-05-11_009965Phase 2Recruiting
- Sponsor
- Mirum Pharmaceuticals, Inc.
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of volixibat in cholestatic pruritus and Primary Sclerosing Cholangitis (PSC) (3 arms), sponsored by Mirum Pharmaceuticals, Inc. Started Apr 2021; status: recruiting.
02
Drugs
volixibat
03
Conditions
cholestatic pruritusPrimary Sclerosing Cholangitis (PSC)
Beyond the preview
Go deeper on MOH_2021-05-11_009965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2021-05-11_009965.